Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2021New England Journal of MedicineOpen Access

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2021 study studied this question.

synapsesocial.com/papers/6a9cb95a2f6d620d5d2f014dhttps://doi.org/10.1056/nejmoa2115624
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel2021 · 1,240 citations
  2. 2Vaccine Effectiveness Studies in the Field2021 · 75 citations
  3. 3Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting2021 · 1,062 citations
  4. 4Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar2021 · 875 citations
  5. 5Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 20212021 · 454 citations